Search

everythinglearnresearchcommunity

for

Search:↓

5% minoxidil foam effectively regrows hair in women, with postmenopausal women seeing the most improvement.

Low iron levels are not linked to hair loss in women with androgenetic alopecia.

Frontal fibrosing alopecia in Bogotá mainly affects postmenopausal women, with possible links to hormonal changes and sunscreen use.

Androgenetic alopecia is not caused by low iron levels.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Postmenopausal women often experience hair loss on the scalp and increased facial hair, but iron supplements may not help.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

A 46-year-old man showed symptoms of a rare condition usually seen in postmenopausal women, highlighting the need for dentist-dermatologist collaboration.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Patients treated with long-term intralesional corticosteroids for alopecia areata should be monitored for bone density changes and advised on osteoporosis prevention.

Balanced hormones are crucial for women's health, and can be managed with lifestyle changes or hormone therapy if needed.

Combination of minoxidil and finasteride is more effective in increasing hair diameter than minoxidil alone for female-pattern hair loss.

Steroid cell tumors in ovaries are rare, can cause hormone changes, and may be cancerous.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Menopausal hormone therapy can improve skin and hair health in menopausal women.

Eating a balanced diet with specific nutrients can help manage menopause symptoms and prevent related health issues.

Healthy aging can be promoted through physical activity, lifestyle changes, and certain treatments.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

Ovariectomized mice mimic postmenopausal hair loss, and estradiol helps maintain hair density.

Finasteride can slow hair loss and promote growth in postmenopausal women.

Aging causes changes in the scalp that can affect hair growth and lead to older-looking hair in women.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.